Parkinson`s disease in Pandemic Covid
Objective: SARS-CoV2 infection invades the brain through ACE2 receptors or the cytotoxic aggregation of proteins, including α-synuclein.Studies are uncertain on the risk of COVID and…Association Between Over-the-Counter Dietary Supplements and Parkinson’s Disease Symptom Severity Over Time
Objective: The goal of this study was to evaluate whether the use of nutraceuticals and dietary supplements are associated, on a population level, with Parkinson’s…Feasibility of artificial intelligence in predicting early phenotype conversion of REM Sleep Behavior Disorder
Objective: The goal of this study was to investigate the feasibility of deep learning in the prediction of disease conversion in RBD patients. Background: Rapid…Blood neurofilament light chain as a biomarker of Parkinson’s disease
Objective: The objective of the study was to analyse blood neurofilament light chain (NfL) levels in patients with Parkinson’s disease (PD) and healthy controls (HCs),…Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline
Objective: To compare rates of self-reported cognitive and motor decline in people with Parkinson’s Disease (PD) with and without a history of head injury (HI).…It takes a village: An interdisciplinary care model for atypical Parkinsonism
Objective: To describe one interdisciplinary clinic designed to offer comprehensive care to patients with atypical parkinsonism syndromes, and to share the lessons learned which may…Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…Pressure Sensor Insole Gait Assessment for Parkinson’s Disease patients: A pilot study
Objective: To assess the correlations between gait characteristics obtained from pressure sensor insoles, and clinical assessments of motor features in Parkinson’s Disease (PD) patients. Background:…Meta-optimization to select stimulation settings for deep brain stimulation in Parkinson’s disease
Objective: The objective is to develop an algorithmic approach for selecting deep brain stimulation (DBS) settings for Parkinson’s disease (PD) and other movement disorders more…Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease
Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
- « Previous Page
- 1
- …
- 794
- 795
- 796
- 797
- 798
- …
- 1942
- Next Page »